PortfoliosLab logoPortfoliosLab logo
SPRY vs. EWTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SPRY vs. EWTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Silverback Therapeutics Inc (SPRY) and Edgewise Therapeutics Inc (EWTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SPRY achieves a -11.76% return, which is significantly lower than EWTX's 56.48% return.


SPRY

1D
3.01%
1M
29.47%
YTD
-11.76%
6M
-6.80%
1Y
-37.96%
3Y*
17.85%
5Y*
-20.88%
10Y*

EWTX

1D
6.38%
1M
18.75%
YTD
56.48%
6M
78.57%
1Y
173.84%
3Y*
72.23%
5Y*
9.21%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SPRY vs. EWTX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
SPRY
Silverback Therapeutics Inc
-11.76%10.43%92.52%-35.76%28.08%-86.68%
EWTX
Edgewise Therapeutics Inc
56.48%-7.06%144.06%22.37%-41.49%-43.41%

Correlation

The correlation between SPRY and EWTX is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Mar 26, 2021

0.26

Fundamentals

Market Cap

SPRY:

$1.02B

EWTX:

$4.16B

EPS

SPRY:

-$2.00

EWTX:

-$1.67

PB Ratio

SPRY:

16.65

EWTX:

8.43

Total Revenue (TTM)

SPRY:

$98.99M

EWTX:

$0.00

Gross Profit (TTM)

SPRY:

$59.93M

EWTX:

$0.00

EBITDA (TTM)

SPRY:

-$194.60M

EWTX:

-$188.16M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SPRY vs. EWTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SPRY
SPRY Risk / Return Rank: 2121
Overall Rank
SPRY Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
SPRY Sortino Ratio Rank: 1919
Sortino Ratio Rank
SPRY Omega Ratio Rank: 2020
Omega Ratio Rank
SPRY Calmar Ratio Rank: 2121
Calmar Ratio Rank
SPRY Martin Ratio Rank: 2626
Martin Ratio Rank

EWTX
EWTX Risk / Return Rank: 9393
Overall Rank
EWTX Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
EWTX Sortino Ratio Rank: 9191
Sortino Ratio Rank
EWTX Omega Ratio Rank: 8888
Omega Ratio Rank
EWTX Calmar Ratio Rank: 9797
Calmar Ratio Rank
EWTX Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SPRY vs. EWTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Silverback Therapeutics Inc (SPRY) and Edgewise Therapeutics Inc (EWTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SPRYEWTXDifference
Sharpe ratioReturn per unit of total volatility

-2.91

Sortino ratioReturn per unit of downside risk

-3.82

Omega ratioGain probability vs. loss probability

0.94

1.39

-0.45

Calmar ratioReturn relative to maximum drawdown

-0.60

8.93

-9.53

Martin ratioReturn relative to average drawdown

-0.85

22.39

-23.25

SPRY vs. EWTX - Sharpe Ratio Comparison

The current SPRY Sharpe Ratio is -0.58, which is lower than the EWTX Sharpe Ratio of 2.34. The chart below compares the historical Sharpe Ratios of SPRY and EWTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SPRY vs. EWTX - Drawdown Comparison

The maximum SPRY drawdown since its inception was -95.20%, which is greater than EWTX's maximum drawdown of -84.69%. Use the drawdown chart below to compare losses from any high point for SPRY and EWTX.


Loading charts...

Drawdown Indicators


SPRYEWTXDifference

Max Drawdown

Largest peak-to-trough decline

-95.20%

-84.69%

-10.51%

Max Drawdown (1Y)

Largest decline over 1 year

-63.32%

-19.59%

-43.73%

Max Drawdown (3Y)

Largest decline over 3 years

-63.32%

-68.81%

+5.49%

Max Drawdown (5Y)

Largest decline over 5 years

-91.77%

-77.14%

-14.63%

Current Drawdown

Current decline from peak

-82.98%

-3.55%

-79.43%

Average Drawdown

Average peak-to-trough decline

-78.26%

-53.27%

-24.99%

Ulcer Index

Depth and duration of drawdowns from previous peaks

44.52%

7.80%

+36.72%

Volatility

SPRY vs. EWTX - Volatility Comparison

The current volatility for Silverback Therapeutics Inc (SPRY) is 18.34%, while Edgewise Therapeutics Inc (EWTX) has a volatility of 22.78%. This indicates that SPRY experiences smaller price fluctuations and is considered to be less risky than EWTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SPRYEWTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.34%

22.78%

-4.44%

Volatility (6M)

Calculated over the trailing 6-month period

45.49%

55.75%

-10.26%

Volatility (1Y)

Calculated over the trailing 1-year period

66.37%

74.79%

-8.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

80.08%

81.58%

-1.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

80.79%

81.12%

-0.33%

Dividends

SPRY vs. EWTX - Dividend Comparison

Neither SPRY nor EWTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SPRY vs. EWTX - Financials Comparison

This section allows you to compare key financial metrics between Silverback Therapeutics Inc and Edgewise Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M20222023202420252026
22.68M
0
(SPRY) Total Revenue
(EWTX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SPRY and EWTX have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

EWTX has higher volatility (22.78%) compared to SPRY (18.34%). In terms of maximum drawdown, SPRY dropped -95.20% vs EWTX's -84.69%.

EWTX currently has the higher Sharpe Ratio (2.34 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SPRY and EWTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer